Introduction
============

Age is the most important non-modifiable risk factor for all subtypes of stroke, particularly ischemic stroke ([@B23]; [@B9]). The incidence of stroke more than doubles in each successive decade after the age of 55 years ([@B23]). The age-standardized stroke incidence in low- and middle-income countries exceeds that in high-income countries by 21% in individuals ≥75 years old, and age-standardized stroke mortality exceeds that in high-income countries by 33%. In addition, the number of lost disability-adjusted life-years is 1.5 times higher in low- and middle-income countries ([@B31]). China has experienced significant growth in its elderly population in recent decades; those ≥75 years old accounted for 3.5% of the population in 2013, and there were 200 million elderly residents ≥65 years old in 2014 ([@B25]; [@B28]).

Population-based studies have indicated that 65% of all strokes occur in individuals \>65 years old (MONICA Project ([@B23]; [@B19]). Moreover, elderly patients have worse functional outcomes after stroke than do younger patients, and these differences persist even after adjusting for stroke risk factors and other comorbidities ([@B7]; [@B13]; [@B3]; [@B12]; [@B27]). A population-based study demonstrated that the incidence of first-ever stroke increased by 4.3% annually in China among those ≥65 years old from 1992 to 2012 ([@B42]).

It is well known that diabetes is significantly associated with stroke, and patients with diabetes mellitus (DM) are at greater risk of stroke than individuals without diabetes ([@B4]; [@B30]; [@B41]). A few studies have investigated the association between DM and long-term prognosis of patients following acute ischemic stroke (AIS; [@B29]; [@B21]); however, the evidence for this association among elderly patients remains controversial. A report from China demonstrated that DM independently predicted poor outcomes within 6 months after AIS in Chinese patients ([@B43]). However, differences in long-term outcomes among elderly stroke patients with DM have not been established.

Therefore, in this study, we aimed to evaluate differences in long-term outcomes between younger patients (\<75 years old) and elderly patients (≥75 years old) with diabetes following AIS from a hospital-based stroke registry in Tianjin, China.

Materials and Methods {#s1}
=====================

All consecutive patients with AIS who were hospitalized in three stroke units in Tianjin, China between January 2006 and September 2014 were recruited for this study. Stroke was defined according to the World Health Organization's criteria, and a diagnosis of AIS was confirmed in all patients based on neuroimaging evidence ([@B1]). Those patients diagnosed with transient ischemic attack were excluded. DM was defined by a previous or new-onset physician diagnosis of DM, or use of hypoglycemic medications.

The ethics committee of Tianjin Medical University General Hospital approved the study, and patients or their next of kin provided written informed consent for participation in accordance with the Declaration of Helsinki.

Data were collected prospectively according to a standardized procedure. Ischemic stroke subtypes, neurological deficits, level of disability at the time of admission, stroke severity, and stroke risk factors were recorded. Levels of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting glucose (FG), and glycosylated hemoglobin (HbA1) at admission also were recorded. During the follow-up period, data on AIS outcomes, including all-cause death, dependency, and recurrence were assessed.

According to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria, ischemic stroke subtypes were classified according to etiology as stroke due to large artery atherothrombosis (LAA), stroke due to cardioembolism (CE), stroke due to small artery occlusion (SAO), stroke of other determined etiology, and stroke of undetermined etiology ([@B24]). Neurological deficits were assessed using the National Institutes of Health stroke scale (NIHSS; [@B22]), and the level of disability was measured using the Barthel index (BI; [@B11]) and modified Rankin scale (mRS; [@B26]). Stroke severity was categorized into three groups based on the NIHSS score: mild (NIHSS: ≤7), moderate (NIHSS: 8--16), and severe (NIHSS: ≥17) ([@B6]).

Risk factors for stroke included a medical history of hypertension, dyslipidemia, atrial fibrillation (AF), and obesity (body mass index ≥30 kg/m^2^); and modifiable lifestyle factors, including current smoking status and alcohol consumption.

Outcome measures for stroke were mortality, recurrence, and dependency rates 12 and 36 months after AIS. Death was defined as all-cause mortality at the corresponding time points after hospital admission. Stroke recurrence was defined as any new-onset vascular event, including stroke, myocardial infarction, and venous thrombosis, at least 30 days after stroke. Dependency was defined as an mRS score ≥3 ([@B10]). Mortality rates at 12 and 36 months after AIS were calculated as the number of all-cause deaths within 12 and 36 months divided by the total number of patients at the corresponding time points. The recurrence rate was calculated as the proportion of patients with new-onset vascular events, including patients who died of vascular events, during the follow-up period. The dependency rate was calculated as the number of patients with an mRS score ≥3 divided by the total number of stroke survivors at 12 and 36 months after AIS.

All patients were categorized into two groups by age: younger group (\<75 years old) and elderly group (≥75 years old). All continuous variables, which included age, NIHSS, BI, mRS, and laboratory values (TC, TG, HDL-C, LDL-C, FG, and HbA1) are presented as the mean (standard deviation) or median (interquartile range, IQR) and compared between groups using the Student's *t*-test or Mann--Whitney *U* test. All categorical variables, including ischemic stroke subtype, stroke severity, and stroke risk factors, are presented as the number (percentage); the differences between groups for categorical variables were analyzed using the Chi-squared test. A multivariate logistic regression analysis was performed to assess factors associated with stroke outcomes by adjusting for covariates (including stroke subtype, severity, and risk factors). The results of the multivariate analysis are presented as adjusted odds ratios (ORs) with 95% confidence intervals (CIs). All statistical analyses were performed using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA), and *P*-values \<0.05 resulting from two-tailed tests were considered statistically significant.

Results
=======

During the study period, 11,330 consecutive patients with AIS were hospitalized in three stroke units. Of these patients, 7,715 patients (68.1%) were excluded because they did not have DM; therefore, 3,615 patients (31.9%) were included in the study. A total of 3,174 patients (94.6%) were analyzed at 12 months after excluding 181 patients (5.4%) who were lost to follow-up among 3,355 patients with a sufficient follow-up time of 12 months. Similarly, 2,232 patients (89.0%) were analyzed at 36 months after excluding 276 patients (11.0%) who were lost to follow-up among 2,508 patients with a sufficient follow-up time of 36 months (**Figure [1](#F1){ref-type="fig"}**).

![**Flow diagram of patients' selection**.](fnagi-08-00142-g001){#F1}

The elderly group included 692 patients (19.1%), more than half of whom (53.6%) were men. Elderly patients were more likely than younger patients to have a TOAST classification of CE (9.6 vs. 2.5%; *P* \< 0.00001). The proportion of patients with moderate and severe stroke were significantly higher in the elderly group than in the younger group (31.5 vs. 26.4%, *P* = 0.007 for moderate stroke; 13.7 vs 8.0%, *P* \< 0.00001 for severe stroke). Similarly, median NIHSS and mRS scores were higher, whereas BI scores were lower, in elderly patients compared with younger patients (all *P* \< 0.001, **Table [1](#T1){ref-type="table"}**).

###### 

Demographical and clinical characteristics in ischemic stroke patients with DM by age.

  Characteristics                            Younger group   Elderly group   *P*
  ------------------------------------------ --------------- --------------- ----------
  Gender, *n* (%):                           2,923 (80.9)    692 (19.1)      \<0.001
      Men                                    1,852 (83.3)    371 (16.7)      
      Women                                  1,071 (76.9)    321 (23.1)      
      Total                                                                  
  TOAST classification, *n* (%):                                             
      Atherothrombotic                       2,066 (71.1)    467 (68.9)      0.099
      Small artery disease                   678 (23.3)      139 (20.5)      0.079
      Cardiac embolism                       73 (2.5)        65 (9.6)        \<0.0001
      Others determined etiology             47 (1.6)        2 (0.3)         0.007
      Undetermined etiology                  42 (1.4)        5 (0.7)         0.136
  Stroke severity, *n* (%):                                                  
      Mild                                   1,918 (65.6)    379 (54.8)      \<0.0001
      Moderate                               772 (26.4)      218 (31.5)      0.007
      Severe                                 233 (8.0)       95 (13.7)       \<0.0001
  Neurological function:                                                     
      NIHSS                                  6 (6)           7 (9)           \<0.001
      BI                                     60 (50)         50 (50)         \<0.001
      mRS                                    3 (2)           4 (1)           \<0.001
  Laboratory examination:                                                    
      Total cholesterol                      5.04 (1.13)     5.01 (1.20)     0.533
      Triglyceride                           1.93 (1.44)     1.56 (0.84)     \<0.001
      High-density lipoprotein cholesterol   1.01 (0.25)     1.05 (0.26)     \<0.001
      Low-density lipoprotein cholesterol    3.10 (0.88)     3.11 (0.94)     0.668

The prevalence of hypertension, dyslipidemia, current smoking, and alcohol consumption was lower in elderly patients compared to younger patients (**Table [2](#T2){ref-type="table"}**); however, an opposite trend was observed for the prevalence of AF (13.6 vs. 4.9%, *P* \< 0.001). There were no significant differences in the prevalence of artery stenosis and obesity between the elderly and younger patients.

###### 

The prevalence of risk factors in ischemic stroke patients with DM by age.

  Previous history of diseases and risk factors   Younger group   Elderly group   *P*
  ----------------------------------------------- --------------- --------------- -----------
  Hypertension                                    2,298 (78.6)    515 (74.4)      0.017
  Atrial fibrillation                             144 (4.9)       94 (13.6)       \<0.00001
  Artery stenosis                                 804 (27.5)      186 (26.9)      0.739
  Dyslipidemias                                   1,135 (38.8)    202 (29.2)      \<0.001
  Obesity                                         487 (16.7)      130 (18.8)      0.182
  Current smoking                                 1,078 (36.9)    110 (15.9)      \<0.001
  Alcohol consumption                             522 (17.9)      32 (4.6)        \<0.001

Mortality, dependency, and recurrence rates at 12 months after stroke were 19.0, 48.5, and 20.9% in the elderly group and 7.4, 30.9, and 15.4% in the younger group, respectively (all *P* \< 0.05). The corresponding rates at 36 months after stroke were 35.4, 78.7, and 53.8% in the elderly group and 13.7, 61.7, and 43.0% in the younger group, respectively (all *P* \< 0.001). After adjusting for stroke subtypes, severity, and risk factors, mortality, dependency, and recurrence rates at 12 and 36 months after stroke were significantly higher in the elderly group than in the younger group. OR (95% CI) at 12 months after stroke was 2.18 (1.64--2.89, *P* \< 0.001) for mortality, 1.81 (1.49--2.20, *P* \< 0.001) for dependency, and 1.37 (1.06--1.76, *P* = 0.016) for recurrence, respectively. The corresponding values at 36 months after stroke were 3.10 (2.35--4.08, *P* \< 0.001) for mortality, 2.04 (1.57--2.34, *P* \< 0.001) for dependency, and 1.40 (1.07--1.85, *P* = 0.016) for recurrence, respectively (**Table [3](#T3){ref-type="table"}**).

###### 

The OR of mortality, recurrence, and dependency at 12 and 36 months after stroke among stroke patients with DM by age^∗^.

  Outcomes         Younger group   Elderly group   Unadjusted          Adjusted^†^                       
  ---------------- --------------- --------------- ------------------- ------------- ------------------- ---------
  12 months:                                                                                             
      Mortality    189 (7.4)       116 (19.0)      2.95 (2.30--3.79)   \<0.001       2.18 (1.64--2.89)   \<0.001
      Dependency   786 (30.7)      296 (48.5)      2.13 (1.78--2.55)   \<0.001       1.81 (1.49--2.20)   \<0.001
      Recurrence   367 (15.4)      102 (20.9)      1.45 (1.14--1.86)   0.003         1.37 (1.06--1.76)   0.016
  36 months:                                                                                             
      Mortality    248 (13.7)      151 (35.4)      3.44 (2.70--4.36)   \<0.001       3.10 (2.35--4.08)   \<0.001
      Dependency   1,113 (61.7)    336 (78.7)      2.30 (1.79--2.95)   \<0.001       2.04 (1.57--2.64)   \<0.001
      Recurrence   636 (43.0)      141 (53.8)      1.54 (1.19--2.01)   \<0.001       1.40 (1.07--1.85)   0.016

∗

OR indicated the risks in elderly group reference as younger group.

†

Indicated adjusted by gender, stroke subtype, severity, and risk factors.

Discussion
==========

In this study, we assessed and compared the outcomes and associated risk factors at 12 and 36 months after AIS between younger patients (\<75 years old) and elderly patients (≥75 years old) with DM in China.

Diabetes mellitus is an independent risk factor for ischemic stroke, as the relative risk of ischemic stroke in patients with DM is 1.8--6.0 times higher than in patients without DM ([@B32]). Moreover, the prevalence of DM ranges from 21 to 44% in patients with AIS ([@B34]; [@B18]). The China National Stroke Registry reported a 26.99% prevalence of DM overall ([@B33]). Consistent with previous studies, we found a 31.9% prevalence of DM among patients with AIS, which was higher than the prevalence determined from the China National Stroke Registry. Different databases of stroke patients between studies may partly explain differences in the frequency of stroke patients with DM.

Previous studies have indicated that ischemic stroke greatly affects the older population ([@B20]; [@B31]; [@B19]; [@B9]). Several studies have reported different trends in the prevalence of hypertension, DM, and AF ([@B26]; [@B3]; [@B22]; [@B11]) among elderly individuals. A study based on a multicenter stroke registry in China reported that patients aged 80 years and older were more likely to have a stroke with a TOAST classification of CE (11.6%). Furthermore, there were higher rates of hypertension (72.1%) and AF (23.4%) and lower rates of DM (17.5%), dyslipidemia (5.6%), current smoking status (22.8%), and heavy drinking (2.5%) among AIS patients ≥80 years old compared to patients \<80 years old ([@B6]). Consistent with these studies, in this study, elderly patients exhibited different clinical features and stroke risk factors than younger patients. The proportions of patients with a TOAST classification of CE, severe stroke, and AF were higher in the elderly group than in the younger group. Younger patients were more likely to have a previous history of hypertension and dyslipidemia and were more likely to be current smokers and alcohol consumers than elderly patients. However, there was no significant difference with respect to artery stenosis or obesity between the two groups.

Previous studies have demonstrated that older patients have worse outcomes after stroke than do younger patients ([@B20]; [@B14]; [@B27]; [@B37], [@B38]). A study conducted in China reported a mortality rate of 34.78%, a dependency rate of 43.81%, and a recurrence rate of 36.02% at 12-month follow-up among AIS patients ≥80 years old ([@B6]). Another study reported that the 1-year case-fatality rate and disability rate in patients ≥80 years old were 33.8 and 37.8%, respectively ([@B38]). Findings from a multivariate analysis in another study revealed that TOAST classification of CE and LAA and moderate and severe stroke were associated with mortality and recurrence 3 months after stroke; moderate and severe stroke also were associated with dependency 3 months after stroke. In addition, moderate and severe stroke were significantly associated with mortality and dependency at 12 months ([@B2]).

Several studies have suggested that DM is associated with a higher stroke mortality rate ([@B45]; [@B34]), but this association was not observed in other studies ([@B39]; [@B44]). Furthermore, many studies have indicated that DM was an important predictive factor for dependency ([@B45]; [@B8]; [@B36]) and recurrence rates ([@B35]; [@B16]; [@B5]) following stroke. However, studies indicated that treatment DM using antidiabetic before or after stroke onset has a meaningful effect on stroke outcome in patients with DM comparing those patients without DM ([@B17]; [@B40]). Age emerged as a highly significant inverse predictor of good functional outcome after ischemic stroke, it was independent of stroke severity, characteristics, and complications. ([@B15]). This study found that mortality, dependency, and recurrence rates were significantly higher in the elderly group than in the younger group among stroke patients with DM at both 12 and 36 months. The mortality, dependency, and recurrence rates in the elderly group were 2.2-, 1.8-, and 1.4-fold higher, respectively, than the corresponding rates in the younger group at 12 months, and were 3.1-, 2.0-, and 1.4-fold higher, respectively, than the corresponding rates in the younger group at 36 months. Age was a predictor of poor long-term outcomes among stroke patients with DM, it was independent of the benefit from treatment using antidiabetic. Worse long-term outcomes in elderly stroke patients with DM may be explained by the limited application of secondary measures for stroke prevention and poor health care services for elderly patients.

There are several limitations to this study. First, all patients were from the local hospital in Tianjin, China, resulting in a limited representation of the general population. Second, all patients were from the local university hospital or neurological specialty hospital, and accordingly, the proportion of patients with severe stroke was higher in this study than in previous studies. However, we adjusted the results by gender, stroke subtype, stroke severity, and risk factors in the multivariate analysis, thus addressing the effect of stroke severity on patient outcomes in our results. Third, pre-stroke information, including medication usage and complications such as pneumonia and urinary tract infection, were not analyzed in this study; therefore, we were unable to assess the impact of these factors on outcomes among elderly patients.

Conclusion
==========

This is the first study to assess the long-term (12 and 36 months) outcomes following AIS between younger and elderly AIS patients with DM in China. Mortality, dependency, and recurrence rates were significantly higher in the elderly group than in the younger group at both 12 and 36 months after AIS. The relationship between age and outcomes remained even after adjusting for stroke subtypes, severity, and risk factors. Age was a predictor of poor long-term outcomes among stroke patients with DM, it was independent of the benefit from treatment using antidiabetic. Poor outcomes in elderly patients may be partly explained by the higher frequency of women, less frequent use of secondary measures to prevent stroke, and poor health care within the elderly population. Thus, management and secondary prevention should be emphasized in elderly patients with DM in China to reduce mortality, recurrence, and dependency after stroke.
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